STAT

OCTOBER 18, 2023

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease. The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the coup

362

362

PharmaVoice

OCTOBER 18, 2023

Organon is partnering with governments, banks, NGOs and investors on programs to improve women’s health through results-based financing.

148

148

STAT

OCTOBER 18, 2023

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United. It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corpo

325

325

The Pharmacist

OCTOBER 18, 2023

More than 31,000 staff – including pharmacists, mental health practitioners and social prescribers – have been recruited to work in general practice under the Additional Roles Reimbursement Scheme (ARRS) since 2019. The total was announced today by NHS England (NHSE), alongside a video to raise awareness of the roles available to patients, after a new […] The post More than 31,000 ARRS staff recruited since 2019 appeared first on The Pharmacist.

109

109

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 18, 2023

Back in the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a floundering program at Novo Nordisk that had been trying to harness the newly-discovered GLP-1 hormone into viable diabetes drug candidates. At the time, many of Knudsen’s bosses had already lost hope for the program. Novo’s focus, after all, was on insulin, and the naturally occurring GLP-1 hormone had too short a half-life to use as a drug.

Diabetes 306

Diabetes 306

Pharmaceutical Technology

OCTOBER 18, 2023

The FDA approved Hyloris’s non-opioid painkiller as the agency increases efforts to mitigate an opioid crisis.

145

145

National Association of Boards of Pharmacy

OCTOBER 18, 2023

Young People and Substance Use Disorder October is Youth Substance Use Prevention Month , highlighting prevention and treatment efforts to keep adolescents drug free. Although drug use has always been a concern for teens, there are specific challenges that today’s youth face. Thankfully, since the coronavirus disease 2019 (COVID-19), a National Institutes of Health survey has shown that illicit use of drugs in teens has decreased, with 11% of eighth graders, 21.5% of 10th graders, and 32.6% of 1

Controlled Substances 111

Controlled Substances 111

STAT

OCTOBER 18, 2023

DALLAS — Treatments like Ozempic, Wegovy, and Mounjaro have been hailed for showing 15% to over 20% weight loss in trials, but those are just averages. In reality, there are big variations in how much weight people lose on the therapies, and it’s unclear what explains those differences. One way researchers are trying to figure this out is by focusing on genes.

301

301

The Pharmacist

OCTOBER 18, 2023

Integrated care boards (ICBs) do not have ‘enough’ pharmacy representation, the Health and Social Care Committee chair Steve Brine has told The Pharmacist. The former pharmacy minister and Conservative MP for Winchester also said he felt primary care networks (PCNs) were ‘way too GP dominated’. Mr Brine was speaking to The Pharmacist following an address […] The post Exclusive: Lack of pharmacy representation on ICBs, warns health committee chair appeared first on The Pharmacist.

103

103

STAT

OCTOBER 18, 2023

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid. But what if long Covid isn’t the right way to think about what they are going through?

298

298

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

OCTOBER 18, 2023

The US Food and Drug Administration (FDA) has approved XPHOZAH ® (tenapanor), the first and only phosphate absorption inhibitor. Ardelyx’s first-in-class oral treatment is indicated to reduce serum phosphorus in adults with chronic kidney disease ( CKD ) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant to phosphate binder therapy.

Adverse Reactions 110

Adverse Reactions Labelling 110

STAT

OCTOBER 18, 2023

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers. Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help.

298

298

BioPharma Dive

OCTOBER 18, 2023

A panel of FDA advisers last month found BrainStorm’s data unconvincing. The company now says a Phase 3b study will be needed for its NurOwn cell therapy to have a shot at an approval.

109

109

STAT

OCTOBER 18, 2023

At the age of 26, Lauren Ghazal was diagnosed with Hodgkin’s lymphoma just months into her Ph.D. program in nursing theory at New York University. She experienced firsthand how the financial burden of undergoing cancer treatment, along with the emotional and physical toll of the disease itself, can lead to overwhelming distress in patients. Now, as an assistant professor at the University of Rochester in the School of Nursing, she researches health and quality of life outcomes among young

288

288

European Pharmaceutical Review

OCTOBER 18, 2023

TZIELD (teplizumab-mzwv) has demonstrated TZIELD’s potential to slow disease progression in newly diagnosed children and adolescents with Stage 3 type 1 diabetes. Data from the Phase III PROTECT clinical trial , presented at the 2023 Annual ISPAD Conference, showed that superior beta cell preservation was observed compared to placebo. As the primary endpoint, 94.9 percent of participants in the TZIELD group maintained peak C-peptide levels ≥0.2 pmol/mL.

Diabetes 108

Diabetes 108

STAT

OCTOBER 18, 2023

During a nearly two-decade stint as Alnylam’s founding CEO, John Maraganore took a promising but unproven approach for treating genetic disease and built a new class of medicines and what is now a nearly $21 billion company. His next goal? Helping the next generation of budding biotech entrepreneurs. Since stepping down as Alnylam CEO in 2021, Maraganore has spent much of his time passing down his knowledge to up-and-coming biotech CEOs.

Drug Development 286

Drug Development 286

Pharma Times

OCTOBER 18, 2023

UK researchers can apply to receive a share of £3m to set up transdisciplinary networks - News - PharmaTimes

130

130

STAT

OCTOBER 18, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a critical look at the mounting Ozempic panic, the case against a former meme stock, and a biotech pivot with a warm reception.

Drug Pricing 242

Drug Pricing Drug Development 242

BioPharma Dive

OCTOBER 18, 2023

CEO Emil Kakkis says the company's findings are too exciting to ignore, but the “high-risk, high-return” venture needs to be pursued outside the organization.

106

106

STAT

OCTOBER 18, 2023

Good morning, everyone, and how are you today? We are doing just fine, thank you. After all, the birds are still chirping and a cool breeze is wafting by the surprisingly sedate Pharmalot campus. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation.

Drug Pricing 242

Drug Pricing 242

PharmaTech

OCTOBER 18, 2023

The California Institute for Regenerative Medicine has partnered with Forge Biologics, which will manufacture AAVs to help accelerate gene therapy programs in California.

105

105

STAT

OCTOBER 18, 2023

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill. Why is the supply of new antibiotics so thin, and growing thinner? A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand.

Hospitals 232

Hospitals 232

Pharmaceutical Technology

OCTOBER 18, 2023

Lisata has received orphan drug designation from the EMA's Committee for Orphan Medicinal Products for LSTA1 to treat pancreatic cancer.

114

114

STAT

OCTOBER 18, 2023

Among drugmakers, big pharma has a reputation of being stodgy and old-fashioned, while biotech startups are seen as rife with fresher thinking — companies where innovative solutions are actually hatched and are then acquired by those older, bigger firms. But at the STAT Summit on Wednesday, Daniel Skovronsky, the chief scientific and medical officer at Eli Lilly, discussed how Lilly has been able to crack both obesity and Alzheimer’s , two areas that have long stumped drug develope

Drug Development 229

Drug Development 229

Pharmaceutical Commerce

OCTOBER 18, 2023

These components take the burden off drug manufacturers to prep packaging components for sterilization, while helping to enhance the drug filling and packaging process.

Packaging 103

Packaging 103

STAT

OCTOBER 18, 2023

The fight over drug prices is far from over. Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — against allowing Medicare to negotiate drug prices, are trying a new tactic to preserve their profits. A group called the Incubate Coalition, comprising the venture capital firms that bankroll most biotech startups, is pressing US lawmakers to extend by four years the time that pills can be on the market before they become subject to price negotiations w

Drug Pricing 218

Drug Pricing 218

Express Pharma

OCTOBER 18, 2023

Glenmark Pharmaceuticals has launched in India the first triple-drug fixed-dose combination (FDC) of teneligliptin with dapagliflozin and metformin. This FDC has been launched under the brand name Zita DM, and it contains the DPP4 inhibitor, Teneligliptin (20 mg), the SGLT2 inhibitor, Dapagliflozin, (10 mg), and Metformin SR (500 mg/1000 mg) in a fixed dose.

Diabetes 99

Diabetes 99

Pharma Times

OCTOBER 18, 2023

Around 700 people in the UK could benefit from the new treatment - News - PharmaTimes

133

133

Express Pharma

OCTOBER 18, 2023

DuPont announced the introduction of its new DuPont Liveo MG 7-9960 Soft Skin Adhesive. The company informed that the “higher-adhesion, low-cyclics silicone soft skin adhesive (SSA) is designed for wound care dressings and adhering medical devices to the skin for long wear time and gentle removal.” it furtner informed, “New DuPont Liveo MG 7-9960 Soft Skin Adhesive has the highest peel adhesion in the Liveo SSA family.

97

97

European Pharmaceutical Review

OCTOBER 18, 2023

Swedish Health authorities have approved contract development and manufacturing organisation (CDMO) Sever Pharma Solutions’ state-of-the-art aseptic filling line. “We are thrilled to announce the approval of our new aseptic filling line for syringes, designed specifically for high potent injectable drugs,” stated Kenneth Stokholm, CEO at Sever Pharma Solutions.

Packaging 94

Packaging Compounding 94

Outsourcing Pharma

OCTOBER 18, 2023

Emma Harvey is global head of medical affairs at F2G Ltd, a UK and Austria based biotech where she is responsible for the global medical and commercial strategies for a novel antifungal drug for serious systemic infections, in clinical development.

87

87

Pharmaceutical Technology

OCTOBER 18, 2023

The company also secured $50m in debt financing to support the commercial launch of Xphozah in November 2023.

109

109

Outsourcing Pharma

OCTOBER 18, 2023

Bioiberica says the excitement for this yearâs CPHI has been âtaken up a notchâ as the company looks forward to welcoming both old and new customers to its hometown, Barcelona.

84

84

Pharmaceutical Technology

OCTOBER 18, 2023

The FDA has granted clearance to UCB’s ZILBRYSQ for the treatment of generalised myasthenia gravis (gMG) in adults.

102

102

Express Pharma

OCTOBER 18, 2023

To showcase new technologies and solutions for the Indian market, B&R Industrial Automation recently organised Innovations Day on August 31, 2023, in Pune to experience the future of automation with ground-breaking innovations, especially for machine builders, system integrators and end users. The event brought esteemed manufacturers and experts from leading companies in machine building together for an event that catapulted some of the finest business presentations, talks from renowned lead

Packaging 80

Packaging 80